
The global cancer burden has shown a distinct shift in the last two decades and its financial impact can be large, even among patients living in high resource countries, with comprehensive health insurance zzso It is hard to imagine its impact on patients of developing countries where insurance policies exist infrequently and often cost becomes the greatest barrier in zzso cancer zzso It is recognized that these costs include the direct cost of disease treatment and care, indirect costs accrued by the patient and the family, and economic losses to the society as a zzso Economic cost analysis or zzso analysis has emerged as a basic tool in the evaluation of health-care zzso To date, these cost data have been collected only zzso even in the most developed countries, and there is a great need for incorporating economic cost assessment practices in developing countries, so that patients and their families can access the care zzso The current review has been done using zzso and zzso search with zzso like cancer, zzso zzso economic burden, medical cost, zzso 

